Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3888-3894.
Prepublished online as a Blood First Edition Paper on August 16, 2005; DOI 10.1182/blood-2004-12-4709.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-12-4709v1
106/12/3888    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appel, S.
Right arrow Articles by Brossart, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appel, S.
Right arrow Articles by Brossart, P.
Related Collections
Right arrow Immunobiology
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

PPAR-{gamma} agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-{kappa}B pathways

Silke Appel, Valdete Mirakaj, Anita Bringmann, Markus M. Weck, Frank Grünebach, and Peter Brossart

From the Department of Hematology, Oncology and Immunology, University of Tübingen, Tübingen, Germany.

Dendritic cells (DCs) play an important role in initiating and maintaining primary immune responses. However, mechanisms involved in the resolution of these responses are elusive. We analyzed the effects of 15d-PGJ2 and the synthetic peroxisome proliferator-activated receptor (PPAR)-{gamma} ligand troglitazone (TGZ) on the immunogenicity of human monocyte-derived DCs upon stimulation with toll-like receptor (TLR) ligands. Activation of PPAR-{gamma} resulted in a reduced stimulation of DCs via the TLR ligands 2, 3, 4, and 7, characterized by down-regulation of costimulatory and adhesion molecules and reduced secretion of cytokines and chemokines involved in T-lymphocyte activation and recruitment. MCP-1 (monocyte chemotactic protein-1) production was increased due to PPAR-{gamma} activation. Furthermore, TGZ-treated DCs showed a significantly reduced capacity to stimulate T-cell proliferation, emphasizing the inhibitory effect of PPAR-{gamma} activation on TLR-induced DC maturation. Western blot analyses revealed that these inhibitory effects on TLR-induced DC activation were mediated via inhibition of the NF-{kappa}B and mitogen-activated protein (MAP) kinase pathways while not affecting the PI3 kinase/Akt signaling. Our data demonstrate that inhibition of the MAP kinase and NF-{kappa}B pathways is critically involved in the regulation of TLR and PPAR-{gamma}-mediated signaling in DCs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. M. Reynolds, Q. Liu, K. C. Brittingham, Y. Liu, M. Gruenthal, C. Z. Gorgun, G. S. Hotamisligil, R. D. Stout, and J. Suttles
Deficiency of Fatty Acid-Binding Proteins in Mice Confers Protection from Development of Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2007; 179(1): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Nencioni, J. Beck, D. Werth, F. Grunebach, F. Patrone, A. Ballestrero, and P. Brossart
Histone Deacetylase Inhibitors Affect Dendritic Cell Differentiation and Immunogenicity
Clin. Cancer Res., July 1, 2007; 13(13): 3933 - 3941.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Debierre-Grockiego, K. Rabi, J. Schmidt, H. Geyer, R. Geyer, and R. T. Schwarz
Fatty Acids Isolated from Toxoplasma gondii Reduce Glycosylphosphatidylinositol-Induced Tumor Necrosis Factor Alpha Production through Inhibition of the NF-{kappa}B Signaling Pathway
Infect. Immun., June 1, 2007; 75(6): 2886 - 2893.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. F. Langer, K. Daub, G. Braun, T. Schonberger, A. E. May, M. Schaller, G. M. Stein, K. Stellos, A. Bueltmann, D. Siegel-Axel, et al.
Platelets Recruit Human Dendritic Cells Via Mac-1/JAM-C Interaction and Modulate Dendritic Cell Function In Vitro
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1463 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Dubrac, P. Stoitzner, D. Pirkebner, A. Elentner, K. Schoonjans, J. Auwerx, S. Saeland, P. Hengster, P. Fritsch, N. Romani, et al.
Peroxisome Proliferator-Activated Receptor-{alpha} Activation Inhibits Langerhans Cell Function
J. Immunol., April 1, 2007; 178(7): 4362 - 4372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Klotz, I. Dani, F. Edenhofer, L. Nolden, B. Evert, B. Paul, W. Kolanus, T. Klockgether, P. Knolle, and L. Diehl
Peroxisome Proliferator-Activated Receptor {gamma} Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy
J. Immunol., February 15, 2007; 178(4): 2122 - 2131.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Gogolak, B. Rethi, I. Szatmari, A. Lanyi, B. Dezso, L. Nagy, and E. Rajnavolgyi
Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPAR{gamma}
Blood, January 15, 2007; 109(2): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Thurnher
Lipids in dendritic cell biology: messengers, effectors, and antigens
J. Leukoc. Biol., January 1, 2007; 81(1): 154 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Rolph, T. R. Young, B. O. V. Shum, C. Z. Gorgun, C. Schmitz-Peiffer, I. A. Ramshaw, G. S. Hotamisligil, and C. R. Mackay
Regulation of Dendritic Cell Function and T Cell Priming by the Fatty Acid-Binding Protein aP2
J. Immunol., December 1, 2006; 177(11): 7794 - 7801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Relic, V. Benoit, N. Franchimont, M.-J. Kaiser, J.-P. Hauzeur, P. Gillet, M.-P. Merville, V. Bours, and M. G. Malaise
Peroxisome Proliferator-activated Receptor-{gamma}1 Is Dephosphorylated and Degraded during BAY 11-7085-induced Synovial Fibroblast Apoptosis
J. Biol. Chem., August 11, 2006; 281(32): 22597 - 22604.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Nencioni, K. Schwarzenberg, K. M. Brauer, S. M. Schmidt, A. Ballestrero, F. Grunebach, and P. Brossart
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Blood, July 15, 2006; 108(2): 551 - 558.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020